November 24, 2025 C-Path Consortium Adds Gene Editing and Advanced Imaging Leaders to Accelerate Alpha-1 Research Beam Therapeutics and the Open Source Imaging Consortium join C-Path’s CPA-1 program, bringing gene editing innovation and...
November 20, 2025 C-Path Announces New Name and Strategic Direction for its PRO Consortium C-Path's PRO Consortium has adopted a new name, the Patient-Centered Evidence Consortium (PCEC), to reflect its...
November 19, 2025 FDA Qualifies C-Path Biomarker GLDH to Detect Liver Injury in Clinical Trials C-Path today announced that the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, through its..
November 18, 2025 C-Path’s International Neonatal Consortium Launches Groundbreaking Neonatal Lab Values GUI Tool to Standardize Reference Ranges in Neonatal Trials TUCSON, Ariz., November 18, 2025 — Critical Path Institute’s® (C-Path) International Neonatal Consortium (INC) today announce
C-Path’s Critical Path for Parkinson’s Names Fatta B. Nahab, MD, as Industry Co-Director TUCSON, Ariz., November 13, 2025 — Critical Path Institute® (C-Path) today announced the appointment of Fatta B. Nahab, M.D., a
October 16, 2025 C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease...
October 14, 2025 Critical Path Institute to be Honored with Reagan-Udall Foundation Innovation Award Award honors regulatory science advances with measurable public health impact; ceremony December 9, 2025, Willard InterContinental
September 30, 2025 C-Path Names Colin Hill to Board of Directors C-Path today announced the election of Colin Hill to its Board of Directors. Hill brings deep experience...
September 11, 2025 C-Path Concludes 2025 Global Impact Conference with Progress Across Rare Diseases, Neurology and Pediatrics Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception...
September 8, 2025 C-Path Welcomes Rare Disease Advocacy Leader Ronald J. Bartek to Board of Directors C-Path today announced the election of Ronald J. Bartek to its Board of Directors.